Janus kinase inhibitor compounds and methods

Details for Australian Patent Application No. 2010258597 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Goodacre, Simon Charles; Lai, Yingjie; Liang, Jun; Magnuson, Steven R.; Robarge, Kirk D.; Stanley, Mark S.; Tsui, Vickie Hsiao-Wei; Williams, Karen; Zhang, Birong; Zhou, Aihe

Agent Spruson & Ferguson

Pub. Number AU-A-2010258597

PCT Pub. Number WO2010/142752

Priority 61/186,322 11.06.09 US

Filing date 10 June 2010

Wipo publication date 16 December 2010

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/142752 Priority application(s): WO2010/142752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258599-PET imaging of fibrogenesis

2010258589-5'-methylthioadenosine neuroprotective properties